粒体自噬
缺氧(环境)
癌症治疗
癌症
白蛋白
化学
癌症研究
细胞生物学
医学
自噬
生物
生物化学
内科学
氧气
细胞凋亡
有机化学
作者
Wenyan Wang,Shunyu Yao,Jingjing Luo,Chendi Ding,Qili Huang,Yao Yang,Zhaoqing Shi,Jiachan Lin,Yu‐Chen Pan,Xiaowei Zeng,Dong‐Sheng Guo,Hongzhong Chen
标识
DOI:10.1038/s41467-025-55905-y
摘要
Hypoxic tumors present a significant challenge in cancer therapy due to their ability to adaptation in low-oxygen environments, which supports tumor survival and resistance to treatment. Enhanced mitophagy, the selective degradation of mitochondria by autophagy, is a crucial mechanism that helps sustain cellular homeostasis in hypoxic tumors. In this study, we develop an azocalix[4]arene-modified supramolecular albumin nanoparticle, that co-delivers hydroxychloroquine and a mitochondria-targeting photosensitizer, designed to induce cascaded oxidative stress by regulating mitophagy for the treatment of hypoxic tumors. These nanoparticles are hypoxia-responsive and release loaded guest molecules in hypoxic tumor cells. The released hydroxychloroquine disrupts the mitophagy process, thereby increasing oxidative stress and further weakening the tumor cells. Additionally, upon laser irradiation, the photosensitizer generates reactive oxygen species independent of oxygen, inducing mitochondria damage and mitophagy activation. The dual action of simultaneous spatiotemporal mitophagy activation and mitophagy flux blockade results in enhanced autophagic and oxidative stress, ultimately driving tumor cell death. Our work highlights the effectiveness of hydroxychloroquine-mediated mitophagy blockade combined with mitochondria-targeted photosensitizer for cascade-amplified oxidative stress against hypoxic tumors. Enhanced mitophagy has been recognized as crucial mechanism to sustain cellular homeostasis in hypoxic tumors. Here, this group fabricates an azocalix[4]arene-modified supramolecular albumin nanoparticle codelivering hydroxychloroquine (HCQ) and sulfur-substituted methylated nile blue analog, capable of inducing cascaded oxidative stress via regulating mitophagy for hypoxic tumors treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI